Dr. Teo Soleymani
๐ค SpeakerAppearances Over Time
Podcast Appearances
So I would say at the very minimum, get a family history or a personal history, get an annual surveillance exam. If you have a lot of moles, I used to direct the Pigmented Lesions and Melanoma Clinic. This is something that was really hard for a lot of dermatologists and patients to follow when they're covered with moles, see which one is changing.
So I would say at the very minimum, get a family history or a personal history, get an annual surveillance exam. If you have a lot of moles, I used to direct the Pigmented Lesions and Melanoma Clinic. This is something that was really hard for a lot of dermatologists and patients to follow when they're covered with moles, see which one is changing.
there are tools that can be utilized, including whole body photography, mole mapping, and some new AI-based softwares that basically track the moles and look for changes as you feed the software more and more pictures from the patients. It's fascinating.
there are tools that can be utilized, including whole body photography, mole mapping, and some new AI-based softwares that basically track the moles and look for changes as you feed the software more and more pictures from the patients. It's fascinating.
there are tools that can be utilized, including whole body photography, mole mapping, and some new AI-based softwares that basically track the moles and look for changes as you feed the software more and more pictures from the patients. It's fascinating.
A lot of the stuff is developing from our, well, I should say my alma mater, but up at Stanford is these AI-based software apps that allow us to survey some of the most challenging patients. So if you have a lot of moles... your screening may be more than once a year. If you have a lot of moles, you inherently have a slightly increased risk for melanoma.
A lot of the stuff is developing from our, well, I should say my alma mater, but up at Stanford is these AI-based software apps that allow us to survey some of the most challenging patients. So if you have a lot of moles... your screening may be more than once a year. If you have a lot of moles, you inherently have a slightly increased risk for melanoma.
A lot of the stuff is developing from our, well, I should say my alma mater, but up at Stanford is these AI-based software apps that allow us to survey some of the most challenging patients. So if you have a lot of moles... your screening may be more than once a year. If you have a lot of moles, you inherently have a slightly increased risk for melanoma.
Now, we always use these terms interchangeably, melanoma, skin cancer, basal, squamous, et cetera. Importantly to know for every one melanoma, there's 10 non-melanoma skin cancers. That's namely basal cell and squamous cell. About 5 million Americans will be diagnosed with one of the non-melanomas this year alone. 5 million. 5 million. It's a big number. Yeah, it's about one in four.
Now, we always use these terms interchangeably, melanoma, skin cancer, basal, squamous, et cetera. Importantly to know for every one melanoma, there's 10 non-melanoma skin cancers. That's namely basal cell and squamous cell. About 5 million Americans will be diagnosed with one of the non-melanomas this year alone. 5 million. 5 million. It's a big number. Yeah, it's about one in four.
Now, we always use these terms interchangeably, melanoma, skin cancer, basal, squamous, et cetera. Importantly to know for every one melanoma, there's 10 non-melanoma skin cancers. That's namely basal cell and squamous cell. About 5 million Americans will be diagnosed with one of the non-melanomas this year alone. 5 million. 5 million. It's a big number. Yeah, it's about one in four.
One in four Americans at some point in their lifetime will develop a skin cancer, encroaching one in three Americans by the end of 2030. So it's a lot. Majority of these are not life-threatening, but they're functionally and cosmetically disfiguring. They arise on sun-exposed areas, so surveillance is really important.
One in four Americans at some point in their lifetime will develop a skin cancer, encroaching one in three Americans by the end of 2030. So it's a lot. Majority of these are not life-threatening, but they're functionally and cosmetically disfiguring. They arise on sun-exposed areas, so surveillance is really important.
One in four Americans at some point in their lifetime will develop a skin cancer, encroaching one in three Americans by the end of 2030. So it's a lot. Majority of these are not life-threatening, but they're functionally and cosmetically disfiguring. They arise on sun-exposed areas, so surveillance is really important.
Yeah, great question. So we are seeing HPV become a real problem in many cancers in the body, not just the original cervical cancer, which was the number one killer in young women for cancer until the vaccine came out. but we're seeing it now as the number one cause of throat cancer in young adults and sexually active adults.
Yeah, great question. So we are seeing HPV become a real problem in many cancers in the body, not just the original cervical cancer, which was the number one killer in young women for cancer until the vaccine came out. but we're seeing it now as the number one cause of throat cancer in young adults and sexually active adults.
Yeah, great question. So we are seeing HPV become a real problem in many cancers in the body, not just the original cervical cancer, which was the number one killer in young women for cancer until the vaccine came out. but we're seeing it now as the number one cause of throat cancer in young adults and sexually active adults.
Significantly increased risk of squamous cell carcinomas in sun-protected areas, immunosuppressed patients. The vaccine, the Gardasil vaccine, which treats or builds immunity to HPV, covers the strains that cause cancer, 16, 18, 31, 33, and so on. I recommend anybody who is either sexually active or anybody who, you know, in population, literally anyone, should get vaccinated.
Significantly increased risk of squamous cell carcinomas in sun-protected areas, immunosuppressed patients. The vaccine, the Gardasil vaccine, which treats or builds immunity to HPV, covers the strains that cause cancer, 16, 18, 31, 33, and so on. I recommend anybody who is either sexually active or anybody who, you know, in population, literally anyone, should get vaccinated.
Significantly increased risk of squamous cell carcinomas in sun-protected areas, immunosuppressed patients. The vaccine, the Gardasil vaccine, which treats or builds immunity to HPV, covers the strains that cause cancer, 16, 18, 31, 33, and so on. I recommend anybody who is either sexually active or anybody who, you know, in population, literally anyone, should get vaccinated.